85 related articles for article (PubMed ID: 29945635)
1. Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer.
Mizuguchi S; Izumi N; Tsukioka T; Komatsu H; Nishiyama N
J Cardiothorac Surg; 2018 Jun; 13(1):78. PubMed ID: 29945635
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer.
Punjabi A; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C; Hiley C; Evison M
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):e331-e338. PubMed ID: 33863615
[TBL] [Abstract][Full Text] [Related]
4. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.
Pinato DJ; Shiner RJ; Seckl MJ; Stebbing J; Sharma R; Mauri FA
Br J Cancer; 2014 Apr; 110(8):1930-5. PubMed ID: 24667648
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
Iwasaki M; Ishihara S; Okada S; Shimegi R; Shimomura M; Inoue M
Ann Surg Oncol; 2022 Sep; 29(9):5699-5707. PubMed ID: 35653068
[TBL] [Abstract][Full Text] [Related]
6. The predictive role of hematologic markers in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study.
Liu W; Ren S; Yang L; Xiao Y; Zeng C; Chen C; Wu F; Hu Y
Int J Surg; 2023 Nov; 109(11):3519-3526. PubMed ID: 37578441
[TBL] [Abstract][Full Text] [Related]
7. Association of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy.
Huang K; Prasad S; Ma SJ; Yu H; Iovoli AJ; Farrugia MK; Dexter EU; Demmy TL; Malik NK; Singh AK
BMC Cancer; 2023 Mar; 23(1):254. PubMed ID: 36932396
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer.
Ohashi K; Nishito Y; Fukuda H; Sadahiro R; Yoshida Y; Watanabe SI; Motoi N; Sonobe Y; Mizuno H; Tsunoda H; Tatsumi K; Suzuki T; Ochiai A; Aoki K
Sci Rep; 2024 Jan; 14(1):429. PubMed ID: 38172491
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer.
Bryant AK; Sankar K; Strohbehn GW; Zhao L; Elliott D; Qin A; Yentz S; Ramnath N; Green MD
Lung Cancer; 2022 Jan; 163():35-41. PubMed ID: 34896803
[TBL] [Abstract][Full Text] [Related]
10. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study.
Samejima H; Kojima K; Fujiwara A; Tokunaga T; Okishio K; Yoon H
BMC Cancer; 2023 Nov; 23(1):1107. PubMed ID: 37964220
[TBL] [Abstract][Full Text] [Related]
11. [Correlation Analysis between Neutrophil-to-lymphocyte Ratio
and the Risk of Malnutrition in Stage IV Primary Lung Cancer].
Xiao P; Pan H; Ma Q; Song L; Zhong D
Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):193-198. PubMed ID: 38590194
[TBL] [Abstract][Full Text] [Related]
12. A peripheral blood biomarker estimates probability of survival: the neutrophil-lymphocyte ratio in noncancer patients.
Davis JL; Moutinho V; Panageas KS; Coit DG
Biomark Med; 2016 Sep; 10(9):953-7. PubMed ID: 27537355
[TBL] [Abstract][Full Text] [Related]
13. Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer.
Iwata K; Suzawa K; Hashimoto K; Tanaka S; Shien K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Jpn J Clin Oncol; 2024 May; ():. PubMed ID: 38704243
[TBL] [Abstract][Full Text] [Related]
14. The Combination of Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio Predicts Survival for Non-small Cell Lung Cancer Patients.
Gong S; Yao X
Ann Surg Oncol; 2023 Jul; 30(7):4062-4063. PubMed ID: 36988752
[No Abstract] [Full Text] [Related]
15. High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma.
Watanabe T; Hosaka T; Ohmori-Matsuda K; Suzuki Y; Suzuki H; Yabuki H; Matsuda Y; Noda M; Sakurada A; Okada Y; Sato Y
Health Sci Rep; 2018 Jun; 1(6):e40. PubMed ID: 30623077
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery.
Ramos R; Macía I; Navarro-Martin A; Déniz C; Rivas F; Ureña A; Masuet-Aumatell C; Moreno C; Nadal E; Escobar I
BMC Pulm Med; 2021 Mar; 21(1):75. PubMed ID: 33653309
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
[TBL] [Abstract][Full Text] [Related]
18. Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm.
Xue M; Li R; Wang K; Liu W; Liu J; Li Z; Ma Z; Zhang H; Tian H; Tian Y
Front Oncol; 2023; 13():1196778. PubMed ID: 37795448
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer.
Pabst L; Lopes S; Bertrand B; Creusot Q; Kotovskaya M; Pencreach E; Beau-Faller M; Mascaux C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108738
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer.
Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
Lung; 2023 Feb; 201(1):95-101. PubMed ID: 36583762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
